Position in VKTX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$10,761,627
-$1,433,412 QoQ
Shares Held
330,720
-4.6% QoQ
Ownership
0.285%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.24903241412676.ToString("F0")%
Shared 0.ToString("F0")%
None 2.750967585873246.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Jun 30, 2024CallValue
$26,505
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. VKTX ranks #101 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in VKTX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,761,627 | 330,720 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $12,195,039 | 346,647 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,196,880 | 578,268 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $13,906,457 | 524,772 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,735,293 | 361,710 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,548,809 | 361,551 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $26,769,555 | 422,833 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $26,505 | 500 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $22,835,752 | 430,782 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $33,818,030 | 412,415 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $41,000 | 500 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $14,341,292 | 770,623 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,663,472 | 692,274 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,561,255 | 404,766 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $108,607 | 6,700 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $13,150,918 | 789,845 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $1,138,860 | 68,400 | Call | Defined | 2023-05-12 | |
| 2022-12-31 | $910,860 | 96,900 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $320,360 | 117,780 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $349,286 | 120,861 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $151,689 | 50,563 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $251,256 | 54,621 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,837,412 | 292,582 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,663,677 | 277,743 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,460,967 | 389,086 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,410,976 | 250,618 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,745,519 | 299,918 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,141,461 | 297,013 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,314,887 | 280,959 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||